Showing results (211-220 of 311) with videos related to

Sort By:
Pageof 32
Movement Disorders : Official Journal of the Movement Disorder Society|January 20, 2024
Transitioning from Subtyping to Precision Medicine in Parkinson's Disease: A Purpose-Driven ApproachConnie Marras, Seyed-Mohammad Fereshtehnejad, Daniela Berg, et al.
JAMA Neurology|August 28, 2013
Association of cerebrospinal fluid β-amyloid 1-42, T-tau, P-tau181, and α-synuclein levels with clinical features of drug-naive patients with early Parkinson diseaseJu-Hee Kang, David J Irwin, Alice S Chen-Plotkin, et al.
Mediators of Inflammation|August 6, 2025
Immunophenotyping of Patients With Rheumatoid Arthritis Reveals Difference in CD27+IgD+ Unswitched Memory B Cell ProfilesBérénice Hansen, Raul Da Costa, Dominique Revets, et al.
NPJ Parkinson'S Disease|September 8, 2021
Heterogeneity of prodromal Parkinson symptoms in siblings of Parkinson disease patientsLuca Baldelli, Sebastian Schade, Silvia Jesús, et al.
Nature Communications|May 9, 2026
High-resolution multi-omics enhances prediction and detection of smORF-encoded proteins in the human gut microbiomeMegan E Davin, Júlia Ortís Sunyer, Luis F Delgado, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 13, 2016
Subtypes of mild cognitive impairment in patients with Parkinson's disease: evidence from the LANDSCAPE studyElke Kalbe, Sarah Petra Rehberg, Ines Heber, et al.
Nature Medicine|May 19, 2026
A multimodal biomarker strategy to enhance diagnostic precision in neurodegenerative parkinsonismIvan Martinez-Valbuena, Maziar Emamikhah, Diana A Olszewska, et al.
Frontiers in Neurology|September 9, 2015
A Practical Guide to Immunoassay Method ValidationUlf Andreasson, Armand Perret-Liaudet, Linda J C van Waalwijk van Doorn, et al.
Frontiers in Aging Neuroscience|July 23, 2016
Prodromal Markers in Parkinson's Disease: Limitations in Longitudinal Studies and Lessons LearnedSebastian Heinzel, Benjamin Roeben, Yoav Ben-Shlomo, et al.
Neurology|June 3, 2024
Association of Plasma Amyloid, P-Tau, GFAP, and NfL With CSF, Clinical, and Cognitive Features in Patients With Dementia With Lewy BodiesKatharina Bolsewig, Annemartijn A J M van Unnik, Elena R Blujdea, et al.
Pageof 32